If you liked this article you might like

Biotech Movers: Immunomedics, Aerie, Exelixis

Biotech Movers: Positive Phase Three Results For Roclatan Send Aerie Shares Soaring

Group Stink; Good, the Bad and the Ugly: Doug Kass' Views

Twitter, Netflix, MetLife: Doug Kass' Views

4 Small-Cap Biotech Stars